Fernand Labrie

Publications

Page 4 of 26, showing 50 records out of 1263 total, starting on record 151, ending on 200

Publication Category Year
3562. Pelletier, G., Lihrmann, I., Dubessy, C., Luu-The, V., Vaudry, D., Labrie, F. (2005) Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord. Neuroscience, 132: 689-696. All publications 2005
3563. Pelletier, G., Luu-The, V., Li, S., Labrie, F. (2005) Localization of type 5 17beta-hydroxysteroid dehydrogenase mRNA in mouse tissues as studies by in situ hybridization. Cell Tissue Res., 320: 393-8. All publications 2005
3565. Pelletier, G., Luu-The, V., Li, S., Labrie, F. (2005) Localization of type 7 17beta-hydroxysteroid dehydrogenase mRNA in mouse tissues. In situ hybridization studies. J Steroid Biochem Mol Biol, 93: 49-57. All publications 2005
3564. Pelletier, G., Luu-The, V., Li, S., Labrie, F. (2005) Localization of type 8 17beta-Hydroxysteroid Dehydrogenase mRNA in Mouse Tissues as Studied by In Situ Hybridization. J. Histochem. & Cytochem., 53: 1257-1271. All publications 2005
3566. Samson, M., Labrie, F., Luu-The, V. (2005) Inhibition of human-type 1 3beta-hydroxysteroid deshydrogenase/delat5-delta4-isomerase expression using siRNA. J Steroid Biochem Mol Biol, 94: 253-7. All publications 2005
4688. Schaid, D.J., Chang, B.L., The International Consortium for Prostate Cancer Genetics. (2005) Description of the International Consortium for Prostate Cancer Genetics, and failure to replicate Linkage of Hereditary Prostate Cancer to 20q13. The Prostate, 63: 276-290. All publications 2005
3567. Soucy, G., Boivin, G., Labrie, F., Rivest, S. (2005) Estradiol is required for a proper immune response to bacterial and viral pathogens in the female brain. J Immunol, 174: 6391-8. All publications 2005
385. Tchédam Ngatcha, B., Luu-The, V., Labrie, F., Poirier, D. (2005) Androsterone 3beta-Ether-3beta-Substituted and Androsterone 3beta-Substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: chemical synthesis and structure-activity relationship. J. Med. Chem., 48: 5257-5268. All publications 2005
3569. Ye, P., Yoshika, M., Labrie, C., Lin, G., Raymond, V., Morissette, J., Labrie, F., St-Amand, J. (2005) Regulation of global gene expression by ovariectomy and estrogen in female white adipose tissue. Obes Res, 13: 1024-30. All publications 2005
3570. Bolduc, C., Larose, M., Yoshioka, M., Ye, P., Belleau, P., Labrie, C., Morissette, J., Raymond, V., Labrie, F., St-Amand, J. (2004) Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression. J Mol Endocrinol, 33: 429-444. All publications 2004
3571. Couture, J.-F., Legrand, P., Cantin, L., Luu-The, V., Labrie, F., Breton, R. (2004) Loop relaxation, a mechanism which explains the reduced specificity of rabbit 20alpha-hydroxysteroid dehydrogenase, a member of the aldo-keto reductase superfamily. J.Mol. Biol., 339: 89-102. All publications 2004
3572. Dumont, M., Frank, D., Moisan, A.-M., Tranchant, M., Soucy, P., Breton, R., Labrie, F., Tavtigian, S.V., Simard, J. (2004) Structure of primate and rodent orthologs of the prostate cancer susceptibility gene ELAC2. Biochimica et Biophysica Acta, 1679: 230-247. All publications 2004
3577. Labrie, F. (2004) Adrenal Androgens and Intracrinology, in: Bruce R. Carr, M.D., eds. Seminars in Reproductive Medicine, New York - Stuttgart, pp 299-309. All publications 2004
21. Labrie, F. (2004) Current status of endocrine therapy in localized prostate cancer: cure has become a strong possibility. Brazilian J Urol, 30: 3-12. All publications 2004
22. Labrie, F. (2004) Major role of androgen blockade in the success of prostate cancer treatment: cure has become a very good possibility. Prostate Cancer Communication Newsletter, 20: 3-11. All publications 2004
23. Labrie, F. (2004) Medical castration with LHRH agonists: 25 years later with major benefits achieved on survival in prostate cancer. J Androl, 25: 305-313. All publications 2004
24. Labrie, F. (2004) Status of androgen blockade in prostate cancer in 2003, in: Koutsilieris, M. et Labrie, F., eds: Prostate cancer: Understanding the pathophysiology and re-designing a therapeutic approach, Athens, Greece, Paschalidis Medical Publications, pp 157-170. All publications 2004
3578. Labrie, F., Candas, B. (2004) Author Response: The Quebec Screening Study Shows a 62% Decrease in Prostate Cancer Death. The Prostate, 61: 373-374. All publications 2004
25. Labrie, F., Candas, B., Cusan, L., Gomez, J.L., Bélanger, A., Brousseau, G., Lévesque, J. (2004) Screening decreases prostate cancer mortality: 11-year follow-up on the 1988 Quebec prospective randomized controlled trial. The Prostate, 59: 311-318. All publications 2004
26. Labrie, F., Candas, B., Cusan, L., Gomez, J.L., Lévesque, J., Chevrette, E., Brousseau, G. (2004) Prostate Cancer Screening and Early Treatment: The Only Possibility for a Major Impact on Survival in Prostate Cancer, in: Labrie, F. et Koutsilieris, M., eds: Prostate Cancer: Understanding the pathophysiology and re-designing a therapeutic approach, Athens, Greece, Paschalidis Medical Publications, pp 67-78. All publications 2004
386. Labrie, F., Champagne, P., Labrie, C., Roy, J., Laverdiere, J., Provencher, L., Potvin, M., Drolet, Y., Pollak, M., Panasci, L., L'Espérance, B., Dufresne, J., Latreille, J., Robert, E., Samson, B., Jolivet, J., Yelle, L., Cusan, L., Diamond, P., Candas, B. (2004) Activity and safety of the orally active precursor of EM-652 (Acolbifene) in Tamoxifen-resistant breast cancer. J Clin Oncol, 22: 864-871. All publications 2004
27. Labrie, F., Cusan, L., Gomez, J., Luu-The, V., Candas, B., Bélanger, A., Labrie, C. (2004) Major impact of hormonal therapy in localized prostate cancer - death can already be an exception. JSBMB, 92: 327-344. All publications 2004
3583. Larose, M., St-Amand, J., Yoshioka, M., Morissette, J., Labrie, C., Raymond, V., Labrie, F. (2004) Transcriptome of mouse uterus by Serial Analysis of Gene Expression: comparison with skeletal muscle. Mol Reprod Dev, 68: 142-148. All publications 2004
3584. Leblanc, M., Bélanger, M.C., Julien, P., Tchernof, A., Labrie, C., Bélanger, A., Labrie, F. (2004) Plasma lipoprotein profile in the male cynomolgus monkey under normal, hypogonadal and combined androgen blockade conditions. J. of Clinical Endocrinology and Metabolism, 89: 1849-1857. All publications 2004
3585. Lepine, J., Bernard, O., Plante, M., Tetu, B., Pelletier, G., Labrie, F., Bélanger, A., Guillemette, C. (2004) Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J. of Clinical Endocrinology and Metabolism, 89: 5222-5232. All publications 2004
3586. Pelletier, G., Luu-The, V., Li, S., Labrie, F. (2004) Localization and estrogenic regulation of androgen receptor mRNA expression in the mouse uterus and vagina. J Endocrinol, 180: 77-85. All publications 2004
3587. Pelletier, G., Luu-The, V., Li, S., Labrie, F. (2004) Localization of 20 alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. Molecular Brain Research, 125: 143-146. All publications 2004
3588. Pelletier, G., Luu-The, V., Li, S., Ouellet, J., Labrie, F. (2004) Cellular localization of mRNA Expression of Enzymes Involved in the Formation and Inactivation of Hormonal Steroids in the Mouse Prostate. J. Histochem & Cytochem., 52: 1351-1356. All publications 2004
3589. Pelletier, G., Luu-The, V., Li, S., Ren, L., Labrie, F. (2004) Localization of 17beta-hydroxysteroid dehydrogenase type 1 mRNA in mouse tissues. J.Mol Endocrinol, 33: 459-465. All publications 2004
28. Qiu, W., Zhou, M., Labrie, F., Lin, S.-X. (2004) Crystal structures of the multi-specific 17beta-hydroxysteroid dehydrogenase type 5: Critical androgen regulation in human peripheral tissues. Mol Endocrinol, 18: 1798-1807. All publications 2004
668. Sancéau, J.-Y., Labrie, F., Gauthier, S. (2004) Synthesis of 14C-labelled EM-800 (SCH 57050) and EM-652. HCI (SCH 57068. HCI, acolbifene), pure selective estrogen receptor modulators. J. of Label Compounds & Radiopharmaceuticals, 47: 741-752. All publications 2004
29. Simard, J., Dumont, M., Soucy, P., Labrie, F., Tavtigian, S.V. (2004) Prostate Cancer Susceptibility Genes, in: Labrie, F. et Koutsilieris, M., eds: Prostate Cancer: Understanding the pathophysiology and re-designing a therapeutic approach, Athens, Greece, Paschalidis Medical Publications, pp 1-38. All publications 2004
590. Tchernof, A., Labrie, F. (2004) Dehydroepiandrosterone, obesity and cardiovascular disease risk. A review of human studies. European Journal of Endocrinology, 151: 1-14. All publications 2004
3594. Akaza, H., Hirao, Y., Labrie, F., Soloway, M.S. (2003) Future prospects for primary hormone therapy in localized and locally advanced prostate cancer. Hinyokika kiyo, Acta Urologica Japonica, 49: 771-7. All publications 2003
3596. Bélanger, A., Pelletier, G., Labrie, F., Barbier, O., Chouinard, S. (2003) Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endoclinol Metab, 14(10): 473-9. All publications 2003
591. Ciobanu, L.C., Luu-The, V., Martel, C., Labrie, F., Poirier, D. (2003) Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase. Cancer Res., 63: 6442-6446. All publications 2003
3598. Couture, J.-F., Legrand, P., Cantin, L., Luu-The, V., Labrie, F., Breton, R, (2003) Human 20alpha-hydroxysteroid dehydrogenase: crystallographic and site-directed mutagenesis studies lead to the identification of an alternative binding site for C21-steroids. J.Mol. Biol., 331: 593-604. All publications 2003
387. Dimitrakakis, C., Zhou, J., Wang, J., Belanger, A., Labrie, F., Cheng, C., Powell, D., Bondy, C. (2003) A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause, 10: 292-298. All publications 2003
3600. Gingras, S., Turgeon, C., Brochu, N., Labrie, F., Simard, J. (2003) Characterization and modulation of sex steroid metabolizing activity in normal human keratinocytes in primary culture and hacat cells. J. Steroid Biochem Mol Biol, 87: 167-79. All publications 2003
388. Gutman, M., Couillard, C., Labrie, F., Candas, B., Labrie, C. (2003) Effect of treatment sequence with radiotherapy and the antiestrogen EM-800 on the growth of ZR-75-1 Human mammary carcinoma in nude mice. Int J Cancer, 103: 268-276. All publications 2003
389. Jensen, J., Kitlen, J., Briand, P., Labrie, F., Lykkesfeldt, A.E. (2003) Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium. J. Steroid Biochem Mol Biol, 84: 469-78. All publications 2003
672. Labrie, F. (2003) Extragonadal synthesis of sex steroïds: Intracrinology. Ann. Endocrinol, 64: 95-107. All publications 2003
30. Labrie, F. (2003) Hormonal therapy in the management of prostate cancer at all stages of the disease, in: Syrigos, K.N., ed. Prostate Cancer: Biology, Diagnosis and Management, London, UK, Oxford University Press, pp 301-314. All publications 2003
3603. Labrie, F. (2003) Médecin spécialiste en endocrinologie, in : Media, Q., ed. 100 carrières de la santé et des services sociaux, Montréal, Canada, Jobboom les éditions, pp 122. All publications 2003
31. Labrie, F., Cusan, L., Gomez, J.L., Candas, B., Bélanger, A., Luu-The, V., Simard, J. (2003) De la biologie à la clinique: le décès dû au cancer de la prostate peut-il maintenant être une exception? Médecine/Sciences, 19: 910-19. All publications 2003
390. Labrie, F., El Alfy, M., Berger, L., Labrie, C., Martel, C., Bélanger, A., Candas, B., Pelletier, G. (2003) The combination of a novel SERM with an estrogen protects the mammary gland and uterus in a rodent model: the future of postmenopausal women's health? Endocrinology, 144: 4700-4706. All publications 2003
391. Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., Pelletier, G. (2003) Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocrine Reviews, 24 (2): 152-182. All publications 2003
596. Leblanc, M., Labrie, C., Bélanger, A., Candas, B., Labrie, F. (2003) Bioavailability and pharmacokinetics of dehydroepiandrosterone in the cynomolgus monkey. J Clin Endocrinol Metab, 88 (9): 4293-302. All publications 2003
597. Lemieux, C., Picard, F., Labrie, F., Richard, D., Deshaies, Y. (2003) The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity. Obes. Res., 11: 477-490. All publications 2003
598. Mauriège, P., Martel, C., Langin, D., Lacaille, M., Després, J.P., Bélanger, A., Labrie, F., Deshaies, Y. (2003) Chronic effects of dehydroepiandrosterone on rat adipose tissue metabolism. Metabolism, 3: 264-272. All publications 2003
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards